As the only patient centric global supply chain provider in the life science industry, Marken stays one step ahead using the latest technology trends and monitoring the drivers that affect our industry and patients. Technology leads the path towards improved clinical trial data and retention. Outsourcing-Pharma , recently noted, the “Clinical grade wearables support “anywhere-anytime” paradigms, allowing clinical trial participants flexibility and CROs better access to data” as a trend having one of the biggest industry impacts.
In the past 24 months, new trends and guidelines have been implemented that direct or impact the pharmaceutical supply chain. From geo-fencing and GPS tracking to GDP compliance, including Annex 15 chapter 6 guidelines, Marken has already put new services and value-added features into place to address the drivers and trends impacting our changing supply chain in order to better serve you.
The increased focus on direct to patient services and orphan disease drug research and treatments is changing the complexity of clinical trials. Big data is helping to optimize the future of the entire supply chain. Work with Marken to ensure you have access to the most complete supply chain solutions to meet the new demand-led supply chain models of our industry.